Alimta: profile and news

Velcade Lung Cancer Study Begins 06 Mar 2006
...look at the safety and possible benefits of combining Velcade with the Eli Lilly (LLY:NYSE - commentary - research - Cramer's Take) drug Alimta in patients ... - TheStreet.com

Combination of Alimta® and Gemzar® for Metastatic Breast Cancer Feb 24, 2006
According to the results of a phase II clinical trial published in the Annals of Oncology, the chemotherapy combination of Alimta® (pemetrexed) and Gemzar ... - Cancer Consultants (press release),

Cancer Drug Hope Mar 3, 2006
Fresh hope was given to lung cancer sufferers today as a leading figure said wonder drug Alimta can extend life longer than previously thought. ... - International News Service,

Mesothelioma Treatment 101 Mar 2, 2006
In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma. ... - Only Idol,

Hana Biosciences Announces Issuance of Talotrexin Patent Feb 14, 2006
Compared to currently available antifolates such as methotrexate or pemetrexed (Alimta(R); Eli Lilly) in preclinical studies, Talotrexin enters into cells up ... - Genetic Engineering News,

'Love cannot just stop' Feb 11, 2006
...die.". Now, she said, they're finding out there is hope. She said a drug, Alimta, gave her husband a few extra months. Panozzo remembers ... - Oakland Press,

Drugs for cancer easy to get in BC Feb 1, 2006
Alimta, which is given with Cisplatin for mesothelioma, a rare form of cancer associated with asbestos exposure, also did not have full funding in Ontario as ... - Globe and Mail,

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
Fourth-Quarter Highlights * Sales increased 6 percent, to $3.879 billion. * Newer products -- Alimta(R), Byetta(R), Cialis(R), Cymbalta(R), Forteo(R), Strattera ... - PR Newswire (press release),

Ely Lilly Posts Profit Beat Jan 26, 2006
...sales of Zyprexa fell 5% to $1.03 billion; sales of Gemzar rose 7% to $352.6 million; sales of Evisa rose 3% to $265.3 million; sales of Alimta rose 86% to ... - TheStreet.com

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
Newer products -- Alimta(R), Byetta(R), Cialis(R ... In the fourth quarter, US sales of Alimta were $86.5 million and sales outside the US were $49.4 million. ... - Finanzen.net,

Combination of Pemetrexed and Oxaliplatin Shows Activity in ... Jan 31, 2006
SAN FRANCISCO, CA -- January 31, 2006 -- Results of said that the combination of pemetrexed (Alimta) and oxaliplatin appears to be an active treatment for ... - DG News

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
Newer products -- Alimta®, Byetta®, Cialis ... In the fourth quarter, US sales of Alimta were $86.5 million and sales outside the US were $49.4 million. ... - Yahoo! News (press release)

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
...* Newer products -- Alimta®, Byetta®, Cialis ... In the fourth quarter, US sales of Alimta were $86.5 million and sales outside the US were $49.4 million. ... - Biotech Intelligence (press release),

Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS ... Jan 26, 2006
For the fourth quarter of 2005, Alimta, a treatment for malignant pleural mesothelioma and second-line treatment of non-small-cell lung cancer, generated sales ... - PharmaLive.com (press release),

Lilly posts 4th-qtr profit on lower tax rate Jan 26, 2006
...for older treatments. Sales of Alimta, a new treatment for lung cancer, rose 86 percent to $136 million. Injectable osteoporosis ... - ABC News

Lilly profit gets new-product boost Jan 26, 2006
Newer products, such as Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve, contributed $791.2 million to fourth-quarter sales ... - MarketWatch

Lilly profit beats forecasts, helped by lower tax Jan 26, 2006
Sales of Alimta, a new treatment for lung cancer, rose 86 percent to $136 million. Sales of Cialis, the anti-impotence pill sold in partnership with ICOS Corp. ... - Reuters

Lilly profit beats forecasts, helped by lower tax Jan 26, 2006
...percent to $265 million. Sales of Alimta, a new treatment for lung cancer, rose 86 percent to $136 million. Sales of Cialis, the ... - Reuters India,

Will New Drugs Gild Lilly? Jan 26, 2006
While sales were once again led by Zyprexa (which was down 5%), newer compounds like Cymbalta, Alimta, and Forteo had the more impressive growth, though of ... - MSNBC

Mesothelioma Treatment 101 Jan 26, 2006
In February 2004, the Food and Drug Administration approved pemetrexed (brand name Alimta) for treatment of malignant pleural mesothelioma. ... - Only Idol,

Why Lilly seems gilded Jan 29, 2006
Sales of Alimta, which was approved for a type of lung cancer in 2004, are expected to blossom as the company wins approval for other indications, and Gemzar ... - Philadelphia Inquirer,

US Oncology Research Network Presents Clinical Studies at ASCO ... Jan 30, 2006
Pemetrexed (ALIMTA(R)), a folate antimetabolite, has demonstrated activity in hepatoma cell lines with a manageable toxicity profile, making it a potentially ... - PharmaLive.com (press release),

Lilly profit beats forecasts, helped by lower tax Jan 26, 2006
...treatment Evista rose 3 percent to $265 million. Sales of Alimta, a new treatment for lung cancer, rose 86 percent to $136 million. - ABC News

Hana Biosciences Announces 2006 Corporate Goals; Key 2005 ... Jan 7, 2006
Compared to currently available antifolates such as methotrexate or pemetrexed (Alimta(R); Eli Lilly) in preclinical studies, Talotrexin enters into cells up ... - Biotech Intelligence (press release),

Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
Our commitment to continuous innovation in cancer care has resulted in enduring therapies such as Gemzar(R) and Alimta(R), which are already helping patients ... - PR Newswire (press release),

Investigational Targeted Therapy May Offer Progress for Non ... Dec 10, 2005
Our commitment to continuous innovation in cancer care has resulted in enduring therapies such as Gemzar® and Alimta®, which are already helping patients ... - Yahoo! News (press release)

'I want to live as long as I can' Dec 7, 2005
..."You want to see as much of your children as you can, to be with your family as long as you can. But a drug called Alimta might help him live a bit longer. ... - BBC News,

Investigational Targeted Therapy May Offer Progress For Non ... Dec 10, 2005
Gemzar(R) (gemcitabine, Eli Lilly and Company) Alimta(R) (pemetrexed, Eli Lilly and Company) (1)Lymphoma Research Foundation, "Learning About Lymphoma ... - news aktuell (Pressemitteilung),

Lilly sees profit topping Wall Street Dec 9, 2005
The other new drugs include Strattera for attention deficit disorder, Forteo for osteoporosis, Xigris for sepsis bloodstream infections, Alimta for cancer and ... - Reuters

Eli Lilly Set For Sales Growth Dec 1, 2005
Schott also expects Lilly to comment on the progress of additional indications for depression drug Cymbalta and cancer treatment Alimta. ... - Forbes

Asbestos drug gets fast-track status Nov 19, 2005
Under its priority system for drug evaluation, the ministry will shorten the review period on Alimta, also known as Pemetrexed, to one year, it said. ... - The Japan Times,

Eli Lilly "buy" Dec 2, 2005
The analyst expects Eli Lilly to provide updates on its Zyprexa, Cymbalta and Alimta drugs, and discuss the progress on prasugrel’s phase III programme. ... - New Ratings

Revealed: Scots patients denied cancer drugs Nov 12, 2005
...are also waiting for authorisation from health board officials later this month before they can give lung cancer patients the drug Alimta, which was approved ... - Scotsman,

Hana Biosciences Announces Positive Interim Results From a Phase I ... Nov 14, 2005
One patient who previously failed pemetrexed (Alimta(R)) has received 8 cycles of talotrexin therapy. Median duration of PR and SD has not been reached. ... - Business Wire (press release),

SF Jury Finds Chrysotile Asbestos Causes Rare Peritoneal ... Nov 18, 2005
After over two years of treatment with chemotherapy, including Alimta®, his cancer is currently in a temporary state of remission. ... - PR Web (press release),

Combination of Alimta® and Gemzar® Does Not Improve Pancreatic ... Sep 21, 2005
According to a study published in the Annals of Oncology, combination chemotherapy with pemetrexed (Alimta®) and gemcitabine (Gemzar®) for treatment of ... - Cancer Consultants (press release),

Oncologic Committee To Meet Nov. 8 On Accelerated Approval ... Oct 7, 2005
AstraZeneca (Iressa), Bristol-Myers Squibb/Imclone (Erbitux), GSK (Bexxar), Lilly (Alimta) and Novartis (Gleevec) have ongoing accelerated approval studies. ... - FDA Advisory Committee

Tomudex® Plus Platinol® Improves Survival of Patients with ... Oct 3, 2005
The anti-metabolite that has been studied the most is Alimta® (pemetrexed) which has been combined with Platinol producing results superior to Platinol alone. ... - Cancer Consultants (press release),

OSI / Genentech / Roche: Tarceva triumphs again Sep 19, 2005
...may be more beneficial to use Tarceva in the first-line setting than currently-used chemotherapy agents such as Pierre Fabre's Navelbine or Eli Lilly's Alimta. ... - Pharmaceutical Business Review

Mesothelioma Community Will Convene to Focus on Cure ... Sep 22, 2005
...peritoneal meso. Systemic chemotherapy protocols will be reviewed, including an assessment of the Alimta/Cisplatin regimen. Second ... - PR Newswire (press release),

Market Strategies Announces 'HALO' Effect of ASCO 2005 Still ... Sep 8, 2005
One product that is expected to see greater usage in NSCLC is ALIMTA, whose actual usage is higher than what Oncologists expected after ASCO. ... - PR Newswire (press release),

Asbestos victims should move to get drug Aug 27, 2005
...lottery. People with diseases caused by the deadly dust in Liverpool and Manchester can use the drug Alimta to relieve their pain. ... - Norwich Evening News,

New drug hope for asbestos victims Aug 10, 2005
Doctors and support groups today welcomed the decision to sanction the use of Alimta for people with advanced cancer of the lungs and chest as a result of ... - Glasgow Evening Times,

Fitch Affirms Eli Lilly & Co.'s 'AA' Senior Unsecured Rating Aug 25, 2005
...and Evista and successful commercialization of the late-stage R&D pipeline, including the potential blockbuster drugs, Cymbalta, Strattera, Alimta, and Cialis. ... - Business Wire (press release),

Sanofi shares gain on Taxotere, synergy hopes Aug 19, 2005
...largest drug market, and rivalry from Roche Holding's (ROG.VX: Quote, Profile, Research) Avastin and Eli Lilly and Co's (LLY.N: Quote, Profile, Research) Alimta ... - Reuters

Research and Markets: Generic Adversity Facing Major Cytotoxics Aug 15, 2005
Despite lower sales, Lilly's reliance on Gemzar and Alimta will intensify compared with that of Sanofi-Aventis by 2010, indicating that Lilly will be at a ... - Business Wire (press release),

Lilly scouts hot Chinese market Aug 14, 2005
Lilly put its Alimta anti-cancer drug in the United States in 2003, allowing it to generate profits to help cover the development cost. ... - Indianapolis Star,

Lilly's 'culture' lessens impact of local job cuts Aug 14, 2005
...since Tippecanoe Labs is a major factor in the development and bulk manufacturing of a number of Lilly's key products, including Gemzar and Alimta for cancer ... - Journal and Courier Online,